Loading compare…
6 funds hold both · as on Jul 2026
Comparing mutual fund co-ownership helps identify hidden asset concentration. Our reverse lookup database shows that 6 mutual funds hold active equity positions in both Alivus Life Sciences and Aurobindo Pharma. The scheme with the highest combined exposure is quant Healthcare Fund (Quant MF), which holds a 7.19% stake in Alivus Life Sciences and a 5.14% stake in Aurobindo Pharma, amounting to a combined conviction weight of 12.33%.
When multiple mutual funds in your portfolio double-up on the same stock pairs, it limits your diversification benefits. If you also hold either of these companies directly in your demat account, your aggregate exposure is amplified. This co-ownership pattern is standard among index-tracking products but represents active, concentrated strategies in equity schemes.
| Fund | Alivus wt. | Aurobindo wt. | Combined |
|---|---|---|---|
| quant Healthcare FundQuant MF · Smart-Beta / Factor | 7.19% | 5.14% | |
| quant Flexi Cap FundQuant MF · Flexi Cap | 1.74% | 6.54% | |
| Back to IndexMotilal Oswal MF · Index Fund | 0.22% | 2.73% | |
| ICICI Prudential Pharma Healthcare and Diagnostics FundICICI Pru MF · Sectoral / Thematic | 1.33% | 0.81% | |
| quant Small Cap FundQuant MF · Small Cap | 0.76% | 0.41% | |
| IB18-Groww Nifty Total Market Index FundGroww MF · Index Fund | 0.01% | 0.15% |
These funds hold both stocks — see how much their entire portfolios overlap.
Check overlap of top funds →“Holds both” = the fund discloses an equity position in each stock in its latest public monthly portfolio (as on Jul 2026). Weight = the position as a % of that fund's portfolio. ISIN-verified from AMC disclosures. Not investment advice.